Organ Health Growth Leverage Natera Prospera organ health tests and multi organ monitoring to pursue partnerships with transplant centers and hospital networks, positioning organ health as a standard of care and enabling long term graft surveillance.

Trials and MRD Leadership Target oncology drug developers and clinical trial sponsors with Signatera ctDNA MRD testing to monitor minimal residual disease and treatment response, leveraging recent collaborations to demonstrate value in real time decision making and trial endpoints.

Women’s Health Expansion Expand women's health portfolio by partnering with OBGYN clinics, fertility centers, and maternal fetal medicine programs to standardize genetic testing as part of care pathways, supported by extensive peer reviewed publications and global lab certifications.

Compliance and Security Edge Differentiate as a trusted data and compliance partner by offering lab governance services to contract labs and healthcare providers, highlighting ISO 13485 and CAP accreditation and CLIA certified labs to reduce risk and ensure rigorous quality.

Data Integration Advantage Sell data integration and analytics capabilities to large health systems and CROs by highlighting Nateras modern data stack including Dell Boomi AtomSphere, Fivetran, Sentry and Salesforce Marketing Cloud for seamless ctDNA data pipelines and scalable reporting.